Executive Decision: Al Monaco
For his "Executive Decision" segment, Cramer once again welcomed Al Monaco, president and CEO of Enbridge (ENB - Get Report), the oil and gas pipeline company whose shares have risen 13% since Cramer last checked in six months ago. Enbridge also currently yields 2.8%.
With over $18 billion in new projects planned, Monaco said Enbridge remains disciplined with its financing and will only be raising capital when it's needed while preserving its credit rating and access to the debt and equity markets. He said that with returns on equity expected to remain in the low double digits, investors can expect dividend boosts in the 10% to 12% range.
When asked about the controversial Keystone XL pipeline, Monaco said our continent needs all of the proposed pipelines in order to keep North American oil and gas in North America. Without them, Canadian producers will have to look to the coast and export their goods to China and elsewhere around the world.Finally, Monaco commented on the economic benefits of pipelines. He said not only do they create jobs, but there are countless spinoff effects as pipelines require materials and equipment and maintenance, all of which are good for the economy. Cramer said that when it comes to pipelines, he likes growth -- which is why Enbridge remains his favorite.
Executive Decision: Stanley BergmanIn his second "Executive Decision" segment, Cramer sat down with Stanley Bergman, chairman and CEO of Henry Schein (HSIC - Get Report), the medical, dental and veterinarian supplier that's seen a 55% gain since Cramer last spoke with Bergman less than 18 months ago. Bergman touted Schein's vet business as one of its keys to growth, noting his company is now the largest supplier to vets all around the world. He said a growing middle class is spending more and more money on their pets and want only the best care for them. Another growth driver for Henry Schein is the dental implant business. Bergman noted that use of implants is growing around the world and new technology will eventually allow patients to get 3-D scans right in their dentist's office, where crowns and bridges can be made while you wait. In the medical world, Bergman said more and more health care is being focused on prevention and wellness, and that means moving more procedures outside of hospitals, where Henry Schein is a primary supplier. Cramer said investors looking for solid and consistent growth should look no further than Henry Schein. To watch replays of Cramer's video segments, visit the Mad Money page on CNBC. To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here. -- Written by Scott Rutt in Washington, D.C. To email Scott about this article, click here: Scott Rutt Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts